<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=7853483" created="20/06/2006" creator="Junko Matsuura"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>7853483</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Regulation of <term id="T1" lex="I_kappa_B_alpha" sem="Protein_molecule">I kappa B alpha</term> and <term id="T2" lex="p105" sem="Protein_molecule">p105</term> in <term id="T3" lex="monocyte" sem="Cell_natural">monocytes</term> and <term id="T4" lex="macrophage" sem="Cell_natural">macrophages</term> persistently infected with <term id="T5" lex="human_immunodeficiency_virus" sem="Virus">human immunodeficiency virus</term>.</sentence>
<event id="E300">
<type class="Regulation"/>
<theme idref="T1"/>
<clue><clueType>Regulation</clueType> <linkTheme>of</linkTheme> I kappa B alpha and p105 <clueLoc>in monocytes</clueLoc> and macrophages <clueLoc>persistently infected with human immunodeficiency virus.</clueLoc></clue>
</event>
<event id="E301">
<type class="Regulation"/>
<theme idref="T1"/>
<clue><clueType>Regulation</clueType> <linkTheme>of</linkTheme> I kappa B alpha and p105 <clueLoc>in</clueLoc> monocytes and <clueLoc>macrophages persistently infected with human immunodeficiency virus.</clueLoc></clue>
</event>
<event id="E302">
<type class="Regulation"/>
<theme idref="T2"/>
<clue><clueType>Regulation</clueType> <linkTheme>of</linkTheme> I kappa B alpha and p105 <clueLoc>in monocytes</clueLoc> and macrophages <clueLoc>persistently infected with human immunodeficiency virus.</clueLoc></clue>
</event>
<event id="E303">
<type class="Regulation"/>
<theme idref="T2"/>
<clue><clueType>Regulation</clueType> <linkTheme>of</linkTheme> I kappa B alpha and p105 <clueLoc>in</clueLoc> monocytes and <clueLoc>macrophages persistently infected with human immunodeficiency virus.</clueLoc></clue>
</event>
<event id="E3">
<type class="Viral_life_cycle"/>
<theme idref="T5"/>
<theme idref="T3"/>
<clue>Regulation of I kappa B alpha and p105 in monocytes and macrophages <clueType>persistently infected</clueType> <linkTheme>with</linkTheme> human immunodeficiency virus.</clue>
</event>
<event id="E4">
<type class="Viral_life_cycle"/>
<theme idref="T5"/>
<theme idref="T4"/>
<clue>Regulation of I kappa B alpha and p105 in monocytes and macrophages <clueType>persistently infected</clueType> <linkTheme>with</linkTheme> human immunodeficiency virus.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">The mechanisms regulating <term id="T6" lex="human_immunodeficiency_virus" sem="Virus">human immunodeficiency virus</term> (<term id="T7" lex="HIV" sem="Virus">HIV</term>) persistence in human <term id="T8" lex="monocyte" sem="Cell_natural">monocytes</term><term id="T9" lex="macrophage" sem="Cell_natural">/macrophages</term> are partially understood.</sentence>
<event KT="Other" id="E310">
<type class="Regulation"/>
<theme idref="T7"/>
<clue>The mechanisms <clueType>regulating</clueType> human immunodeficiency virus (HIV) persistence <clueLoc>in human monocytes</clueLoc>/macrophages are partially understood.</clue>
</event>
<event KT="Other" id="E311">
<type class="Regulation"/>
<theme idref="T7"/>
<clue>The mechanisms <clueType>regulating</clueType> human immunodeficiency virus (HIV) persistence <clueLoc>in human</clueLoc> monocytes/<clueLoc>macrophages</clueLoc> are partially understood.</clue>
</event>
<sentence id="S3">Persistent <term id="T10" lex="HIV_infection" sem="Other"><term id="T11" lex="HIV" sem="Virus">HIV</term> infection</term> of <term id="T12" lex="U937_monocytic_cell" sem="Cell_cultured">U937 monocytic cells</term> results in <term id="T13" lex="NF-kappa_B_activation" sem="Other"><term id="T14" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> activation</term>.</sentence>
<event KT="Other" id="E7">
<type class="Viral_life_cycle"/>
<theme idref="T11"/>
<theme idref="T12"/>
<clue><clueType>Persistent</clueType> HIV <clueType>infection</clueType> <linkTheme>of</linkTheme> U937 monocytic cells results in NF-kappa B activation.</clue>
</event>
<event KT="Fact" id="E8">
<type class="Positive_regulation"/>
<theme idref="T14"/>
<cause idref="E7"/>
<clue>Persistent HIV infection of U937 monocytic cells results in NF-kappa B <clueType>activation</clueType>.</clue>
</event>
<sentence id="S4">Whether <term id="A1" sem="Virus">virus</term>-induced <term id="T15" lex="NF-kappa_B_activation" sem="Other"><term id="T16" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> activation</term> is a mechanism that favors continuous <term id="A2" sem="Virus">viral</term> replication in <term id="T17" lex="macrophage" sem="Cell_natural">macrophages</term> remains unknown.</sentence>
<event KT="Other" id="E10">
<type class="Positive_regulation"/>
<theme idref="T16"/>
<cause idref="A1"/>
<clue>Whether virus-<linkCause>induced</linkCause> NF-kappa B <clueType>activation</clueType> is a mechanism that favors continuous viral replication in macrophages remains unknown.</clue>
</event>
<event KT="Other" id="E11">
<type class="Viral_life_cycle"/>
<theme idref="A2"/>
<clue>Whether virus-induced NF-kappa B activation is a mechanism that favors continuous viral <clueType>replication</clueType> <clueLoc>in macrophages</clueLoc> remains unknown.</clue>
</event>
<event CL="L1" KT="Analysis" id="E12" uncertainty="doubtful">
<type class="Positive_regulation"/>
<theme idref="E11"/>
<cause idref="E10"/>
<clue><clueKT>Whether</clueKT> virus-induced NF-kappa B activation is a mechanism that <clueType>favors</clueType> continuous viral replication in macrophages <clueKT><clueCL>remains unknown</clueCL></clueKT>.</clue>
</event>
<sentence id="S5">To further delineate the molecular mechanisms involved in the activation of <term id="T18" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> in <term id="T19" lex="HIV" sem="Virus">HIV</term>-infected <term id="T20" lex="monocyte" sem="Cell_natural">monocytes</term> and <term id="T21" lex="macrophage" sem="Cell_natural">macrophages</term>, we have focused on the regulation of the <term id="A3" sem="Protein_molecule">I kappa B</term> molecules.</sentence>
<event KT="Other" id="E320">
<type class="Positive_regulation"/>
<theme idref="T18"/>
<clue>To further delineate the molecular mechanisms involved in the <clueType>activation</clueType> <linkTheme>of</linkTheme> NF-kappa B <clueLoc>in HIV-infected monocytes</clueLoc> and macrophages, we have focused on the regulation of the I kappa B molecules.</clue>
</event>
<event KT="Other" id="E321">
<type class="Positive_regulation"/>
<theme idref="T18"/>
<clue>To further delineate the molecular mechanisms involved in the <clueType>activation</clueType> <linkTheme>of</linkTheme> NF-kappa B <clueLoc>in HIV-infected</clueLoc> monocytes and <clueLoc>macrophages</clueLoc>, we have focused on the regulation of the I kappa B molecules.</clue>
</event>
<event KT="Investigation" id="E14">
<type class="Regulation"/>
<theme idref="A3"/>
<clue>To further delineate the molecular mechanisms involved in the activation of NF-kappa B in HIV-infected monocytes and macrophages, we have <clueKT>focused</clueKT> on the <clueType>regulation</clueType> <linkTheme>of</linkTheme> the I kappa B molecules.</clue>
</event>
<sentence id="S6">First, we show that persistent <term id="T22" lex="HIV" sem="Virus">HIV</term> infection results in the activation of <term id="A4" sem="Protein_molecule">NF-kappa B</term> not only in monocytic cells but also in <term id="T23" lex="macrophage" sem="Cell_natural">macrophages</term>.</sentence>
<event KT="Other" id="E15">
<type class="Viral_life_cycle"/>
<theme idref="T22"/>
<clue>First, we show that <clueType>persistent</clueType> HIV <clueType>infection</clueType> results in the activation of NF-kappa B not only in monocytic cells but also in macrophages.</clue>
</event>
<event KT="Analysis" id="E330">
<type class="Positive_regulation"/>
<theme idref="A4"/>
<cause idref="E15"/>
<clue>First, we <clueKT>show</clueKT> that persistent HIV infection results in the <clueType>activation</clueType> <linkTheme>of</linkTheme> NF-kappa B not only <clueLoc>in monocytic cells</clueLoc> but also in macrophages.</clue>
</event>
<event KT="Analysis" id="E331">
<type class="Positive_regulation"/>
<theme idref="A4"/>
<cause idref="E15"/>
<clue>First, we <clueKT>show</clueKT> that persistent HIV infection results in the <clueType>activation</clueType> <linkTheme>of</linkTheme> NF-kappa B not only in monocytic cells but also <clueLoc>in macrophages</clueLoc>.</clue>
</event>
<sentence id="S7">In <term id="T24" lex="HIV" sem="Virus">HIV</term>-infected cells, <term id="T25" lex="I_kappa_B_alpha" sem="Protein_molecule">I kappa B alpha</term> protein levels are decreased secondary to enhanced <term id="A10" sem="Other">protein degradation</term>.</sentence>
<event id="E19">
<type class="Initiation_of_viral_infection"/>
<theme idref="T24"/>
<clue>In HIV-<clueType>infected</clueType> cells, I kappa B alpha protein levels are decreased secondary to enhanced protein degradation.</clue>
</event>
<event id="E20">
<type class="Positive_regulation"/>
<theme idref="A10"/>
<clue>In HIV-infected cells, I kappa B alpha protein levels are decreased secondary to <clueType>enhanced</clueType> protein degradation.</clue>
</event>
<event id="E21">
<type class="Negative_regulation"/>
<theme idref="T25"/>
<cause idref="E20"/>
<clue><clueLoc>In HIV-infected cells</clueLoc>, I kappa B alpha protein levels are <clueType>decreased</clueType> <linkCause>secondary to</linkCause> enhanced protein degradation.</clue>
</event>
<sentence id="S8">This parallels the increased <term id="T26" lex="I_kappa_B_alpha" sem="Protein_molecule">I kappa B alpha</term> synthesis secondary to increased <term id="T27" lex="I_kappa_B_alpha" sem="Protein_molecule">I kappa B alpha</term> gene transcription, i.e., increased <term id="A21" sem="RNA_molecule">RNA</term> and transcriptional activity of its <term id="A22" sem="DNA_domain_or_region">promoter-enhancer</term>.</sentence>
<event id="E23">
<type class="Transcription"/>
<theme idref="T27"/>
<clue>This parallels the increased I kappa B alpha synthesis secondary to increased I kappa B alpha gene <clueType>transcription</clueType>, i.e., increased RNA and transcriptional activity of its promoter-enhancer.</clue>
</event>
<event id="E24">
<type class="Positive_regulation"/>
<theme idref="E23"/>
<clue>This parallels the increased I kappa B alpha synthesis secondary to <clueType>increased</clueType> I kappa B alpha gene transcription, i.e., increased RNA and transcriptional activity of its promoter-enhancer.</clue>
</event>
<event id="E25">
<type class="Translation"/>
<theme idref="T26"/>
<clue>This parallels the increased I kappa B alpha <clueType>synthesis</clueType> secondary to increased I kappa B alpha gene transcription, i.e., increased RNA and transcriptional activity of its promoter-enhancer.</clue>
</event>
<event id="E26">
<type class="Positive_regulation"/>
<theme idref="E25"/>
<cause idref="E24"/>
<clue>This parallels the <clueType>increased</clueType> I kappa B alpha synthesis <linkCause>secondary to</linkCause> increased I kappa B alpha gene transcription, i.e., increased RNA and transcriptional activity of its promoter-enhancer.</clue>
</event>
<event KT="Analysis" id="E27">
<type class="Correlation"/>
<theme idref="E21"/>
<theme idref="E26"/>
<clue><corefTheme idref1="E21">This</corefTheme> <clueType><clueKT>parallels</clueKT></clueType> the increased I kappa B alpha synthesis secondary to increased I kappa B alpha gene transcription, i.e., increased RNA and transcriptional activity of its promoter-enhancer.</clue>
</event>
<event id="E61">
<type class="Positive_regulation"/>
<theme idref="A21"/>
<clue>This parallels the increased I kappa B alpha synthesis secondary to increased I kappa B alpha gene transcription, i.e., <clueType>increased</clueType> RNA and transcriptional activity of its promoter-enhancer.</clue>
</event>
<event id="E62">
<type class="Transcription"/>
<theme idref="T27" idref1="A22"/>
<clue>This parallels the increased I kappa B alpha synthesis secondary to increased I kappa B alpha gene transcription, i.e., increased RNA and <clueType>transcriptional activity</clueType> <linkCause>of</linkCause> <linkCause>its</linkCause> promoter-enhancer.</clue>
</event>
<event id="E63">
<type class="Positive_regulation"/>
<theme idref="E62"/>
<clue>This parallels the increased I kappa B alpha synthesis secondary to increased I kappa B alpha gene transcription, i.e., <clueType>increased</clueType> RNA and transcriptional activity of its promoter-enhancer.</clue>
</event>
<sentence id="S9">Another protein with I kappa B function, <term id="T28" lex="p105" sem="Protein_molecule">p105</term>, is also modified in <term id="T29" lex="HIV" sem="Virus">HIV</term>-infected cells: <term id="T30" lex="p105" sem="Protein_molecule">p105</term> and <term id="T31" lex="p50" sem="Protein_molecule">p50</term> <term id="T32" lex="steady-state_protein_level" sem="Other">steady-state protein levels</term> are increased as a result of increased synthesis and proteolytic processing of <term id="T33" lex="p105" sem="Protein_molecule">p105</term>.</sentence>
<event id="E28">
<type class="Regulation"/>
<theme idref="T28"/>
<clue>Another protein with I kappa B function, p105, is also <clueType>modified</clueType> <clueLoc>in HIV-infected cells</clueLoc>: p105 and p50 steady-state protein levels are increased as a result of increased synthesis and proteolytic processing of p105.</clue>
</event>
<event id="E29">
<type class="Translation"/>
<theme idref="T33"/>
<clue>Another protein with I kappa B function, p105, is also modified in HIV-infected cells: p105 and p50 steady-state protein levels are increased as a result of increased <clueType>synthesis</clueType> and proteolytic processing <linkTheme>of</linkTheme> p105.</clue>
</event>
<event id="E30">
<type class="Protein_processing"/>
<theme idref="T33"/>
<clue>Another protein with I kappa B function, p105, is also modified in HIV-infected cells: p105 and p50 steady-state protein levels are increased as a result of increased synthesis and <clueType>proteolytic processing</clueType> <linkTheme>of</linkTheme> p105.</clue>
</event>
<event id="E31">
<type class="Positive_regulation"/>
<theme idref="E29"/>
<clue>Another protein with I kappa B function, p105, is also modified <clueLoc>in HIV-infected cells</clueLoc>: p105 and p50 steady-state protein levels are increased as a result of <clueType>increased</clueType> synthesis and proteolytic processing of p105.</clue>
</event>
<event id="E32">
<type class="Positive_regulation"/>
<theme idref="E30"/>
<clue>Another protein with I kappa B function, p105, is also modified <clueLoc>in HIV-infected cells</clueLoc>: p105 and p50 steady-state protein levels are increased as a result of <clueType>increased</clueType> synthesis and proteolytic processing of p105.</clue>
</event>
<event id="E33">
<type class="Positive_regulation"/>
<theme idref="T30"/>
<cause idref="E31"/>
<clue>Another protein with I kappa B function, p105, is also modified in HIV-infected cells: p105 and p50 steady-state protein levels are <clueType>increased</clueType> <linkCause>as a result of</linkCause> increased synthesis and proteolytic processing of p105.</clue>
</event>
<event id="E34">
<type class="Positive_regulation"/>
<theme idref="T30"/>
<cause idref="E32"/>
<clue>Another protein with I kappa B function, p105, is also modified in HIV-infected cells: p105 and p50 steady-state protein levels are <clueType>increased</clueType> <linkCause>as a result of</linkCause> increased synthesis and proteolytic processing of p105.</clue>
</event>
<event id="E35">
<type class="Positive_regulation"/>
<theme idref="T31"/>
<cause idref="E31"/>
<clue>Another protein with I kappa B function, p105, is also modified in HIV-infected cells: p105 and p50 steady-state protein levels are <clueType>increased</clueType> <linkCause>as a result of</linkCause> increased synthesis and proteolytic processing of p105.</clue>
</event>
<event id="E36">
<type class="Positive_regulation"/>
<theme idref="T31"/>
<cause idref="E32"/>
<clue>Another protein with I kappa B function, p105, is also modified in HIV-infected cells: p105 and p50 steady-state protein levels are <clueType>increased</clueType> <linkCause>as a result of</linkCause> increased synthesis and proteolytic processing of p105.</clue>
</event>
<event id="E65">
<type class="Viral_life_cycle"/>
<theme idref="T29"/>
<clue>Another protein with I kappa B function, p105, is also modified in HIV-<clueType>infected</clueType> cells: p105 and p50 steady-state protein levels are increased as a result of increased synthesis and proteolytic processing of p105.</clue>
</event>
<sentence id="S10">Transcriptional activity of <term id="T34" lex="p105" sem="Protein_molecule">p105</term> is also increased in <term id="T35" lex="infected_cell" sem="Cell_natural">infected cells</term> and is also mediated by <term id="T36" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> through a specific <term id="T37" lex="kappa_B_motif" sem="DNA_domain_or_region">kappa B motif</term>.</sentence>
<event id="E37">
<type class="Transcription"/>
<theme idref="T34"/>
<clue><clueType>Transcriptional activity</clueType> <linkTheme>of</linkTheme> p105 is also increased in infected cells and is also mediated by NF-kappa B through a specific kappa B motif.</clue>
</event>
<event id="E38">
<type class="Positive_regulation"/>
<theme idref="E37"/>
<clue>Transcriptional activity of p105 is also <clueType>increased</clueType> <clueLoc>in infected cells</clueLoc> and is also mediated by NF-kappa B through a specific kappa B motif.</clue>
</event>
<event id="E39">
<type class="Positive_regulation"/>
<theme idref="E37"/>
<cause idref="T36"/>
<clue>Transcriptional activity of p105 is also increased in infected cells and is also <clueType>mediated</clueType> <linkCause>by</linkCause> NF-kappa B through a specific kappa B motif.</clue>
</event>
<event id="E40">
<type class="Correlation"/>
<theme idref="E39"/>
<theme idref="T37"/>
<clue>Transcriptional activity of p105 is also increased in infected cells and is also mediated by NF-kappa B <linkTheme>through</linkTheme> a specific kappa B motif.</clue>
<comment>NO CLUETYPE</comment></event>
<event id="E66">
<type class="Viral_life_cycle"/>
<theme idref="T29"/>
<clue>Transcriptional activity of p105 is also increased in <clueType>infected</clueType> cells and is also mediated by NF-kappa B through a specific kappa B motif.</clue>
<comment>NO COREFTHEME</comment></event>
<sentence id="S11">These results demonstrate the existence of a <term id="A5" sem="Other">triple autoregulatory loop</term> in <term id="T39" lex="monocyte" sem="Cell_natural">monocytes</term> and <term id="T40" lex="macrophage" sem="Cell_natural">macrophages</term> involving <term id="T41" lex="HIV" sem="Virus">HIV</term>, <term id="T42" lex="p105" sem="Protein_molecule">p105</term> and <term id="T43" lex="p50" sem="Protein_molecule">p50</term>, and <term id="T44" lex="MAD3" sem="Protein_molecule">MAD3</term>, with the end result of persistent <term id="T45" lex="NF-kappa_B_activation" sem="Other"><term id="T46" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> activation</term> and <term id="T47" lex="viral_persistence" sem="Other">viral persistence</term>.</sentence>
<event KT="Other" Manner="High" id="E41">
<type class="Positive_regulation"/>
<theme idref="T46"/>
<clue>These results demonstrate the existence of a triple autoregulatory loop in monocytes and macrophages involving HIV, p105 and p50, and MAD3, with the end result of <clueManner>persistent</clueManner> NF-kappa B <clueType>activation</clueType> and viral persistence.</clue>
</event>
<event KT="Analysis" id="E340">
<type class="Regulation"/>
<theme idref="T41"/>
<theme idref="T42"/>
<theme idref="T43"/>
<theme idref="T44"/>
<clue>These results <clueKT>demonstrate</clueKT> the existence of a <clueType>triple autoregulatory loop</clueType> <clueLoc>in monocytes</clueLoc> and macrophages <linkTheme>involving</linkTheme> HIV, p105 and p50, and MAD3, with the end result of persistent NF-kappa B activation and viral persistence.</clue>
<comment>NER T38 DEL</comment></event>
<event KT="Analysis" id="E341">
<type class="Regulation"/>
<theme idref="T41"/>
<theme idref="T42"/>
<theme idref="T43"/>
<theme idref="T44"/>
<clue>These results <clueKT>demonstrate</clueKT> the existence of a <clueType>triple autoregulatory loop</clueType> <clueLoc>in</clueLoc> monocytes and <clueLoc>macrophages</clueLoc> <linkTheme>involving</linkTheme> HIV, p105 and p50, and MAD3, with the end result of persistent NF-kappa B activation and viral persistence.</clue>
<comment>NER T38 DEL</comment></event>
<event KT="Analysis" id="E342">
<type class="Positive_regulation"/>
<theme idref="E41"/>
<cause idref="E340"/>
<clue>These results <clueKT>demonstrate</clueKT> the existence of a triple autoregulatory loop in monocytes and macrophages involving HIV, p105 and p50, and MAD3, with the <clueType>end result</clueType> <linkTheme>of</linkTheme> persistent NF-kappa B activation and viral persistence.</clue>
</event>
<event KT="Analysis" id="E343">
<type class="Positive_regulation"/>
<theme idref="E41"/>
<cause idref="E341"/>
<clue>These results <clueKT>demonstrate</clueKT> the existence of a triple autoregulatory loop in monocytes and macrophages involving HIV, p105 and p50, and MAD3, with the <clueType>end result</clueType> <linkTheme>of</linkTheme> persistent NF-kappa B activation and viral persistence.</clue>
</event>
<event KT="Analysis" id="E344">
<type class="Positive_regulation"/>
<theme idref="T47"/>
<cause idref="E340"/>
<clue>These results <clueKT>demonstrate</clueKT> the existence of a triple autoregulatory loop in monocytes and macrophages involving HIV, p105 and p50, and MAD3, with the <clueType>end result</clueType> <linkTheme>of</linkTheme> persistent NF-kappa B activation and viral persistence.</clue>
</event>
<event KT="Analysis" id="E345">
<type class="Positive_regulation"/>
<theme idref="T47"/>
<cause idref="E341"/>
<clue>These results <clueKT>demonstrate</clueKT> the existence of a triple autoregulatory loop in monocytes and macrophages involving HIV, p105 and p50, and MAD3, with the <clueType>end result</clueType> <linkTheme>of</linkTheme> persistent NF-kappa B activation and viral persistence.</clue>
</event>
<sentence id="S12">Furthermore, persistent <term id="T48" lex="HIV" sem="Virus">HIV</term> infection of <term id="T49" lex="monocyte" sem="Cell_natural">monocytes</term> and <term id="T50" lex="macrophage" sem="Cell_natural">macrophages</term> provides a useful model with which to study concomitant modifications of different <term id="T51" lex="I_kappa_B_molecule" sem="Protein_family_or_group">I kappa B molecules</term>.</sentence>
<event KT="Other" id="E51">
<type class="Viral_life_cycle"/>
<theme idref="T48"/>
<theme idref="T49"/>
<clue>Furthermore, <clueType>persistent</clueType> HIV <clueType>infection</clueType> <linkTheme>of</linkTheme> monocytes and macrophages provides a useful model with which to study concomitant modifications of different I kappa B molecules.</clue>
</event>
<event KT="Other" id="E52">
<type class="Viral_life_cycle"/>
<theme idref="T48"/>
<theme idref="T50"/>
<clue>Furthermore, <clueType>persistent</clueType> HIV <clueType>infection</clueType> <linkTheme>of</linkTheme> monocytes and macrophages provides a useful model with which to study concomitant modifications of different I kappa B molecules.</clue>
</event>
<event KT="Investigation" id="E53">
<type class="Regulation"/>
<theme idref="T51"/>
<clue>Furthermore, persistent HIV infection of monocytes and macrophages provides a useful model with which to <clueKT>study</clueKT> concomitant <clueType>modifications</clueType> <linkTheme>of</linkTheme> different I kappa B molecules.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
